Cui-cui Zhao

Key Laboratory Of Cancer Prevention And Therapy, Key Laboratory Of Breast Cancer Prevention And Therapy
Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Azobenzene-based liposomes with nanomechanical action for cytosolic chemotherapeutic drug delivery.

Azobenzene-based liposomes with nanomechanical action for cytosolic chemotherapeutic drug delivery.

Journal: Colloids and surfaces. B, Biointerfaces
Published: July 11, 2024

NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression.

NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression.

Journal: Thoracic cancer
Published: January 19, 2024

Engineering biomimetic nanosystem targeting multiple tumor radioresistance hallmarks for enhanced radiotherapy.

Engineering biomimetic nanosystem targeting multiple tumor radioresistance hallmarks for enhanced radiotherapy.

Journal: Science China. Life sciences
Published: November 20, 2023

Paclitaxel-based supramolecular hydrogel loaded with mifepristone for the inhibition of breast cancer metastasis.

Paclitaxel-based supramolecular hydrogel loaded with mifepristone for the inhibition of breast cancer metastasis.

Journal: Cancer science
Published: July 24, 2021

KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.

KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.

Journal: BioMed research international
Published: July 22, 2021

KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer.

KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer.

Journal: Journal of oncology
Published: January 10, 2021

Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis.

Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis.

Journal: Bioscience reports
Published: November 12, 2020

[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.

[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.

Journal: Oncology reports
Published: April 13, 2018

Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.

Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.

Journal: Oncology reports
Published: April 13, 2018
Showing 1-9 of 9

Last Updated: 09/26/2026